Complications of transradial versus transfemoral access for neuroendovascular procedures: a meta-analysis.


Journal

Journal of neurointerventional surgery
ISSN: 1759-8486
Titre abrégé: J Neurointerv Surg
Pays: England
ID NLM: 101517079

Informations de publication

Date de publication:
Aug 2022
Historique:
received: 14 07 2021
accepted: 23 08 2021
pubmed: 5 9 2021
medline: 19 7 2022
entrez: 4 9 2021
Statut: ppublish

Résumé

Transradial access (TRA) has gained increased usage among neurointerventionalists. However, the overall safety profile of access site complications (ASCs) and non-access site complications (NASCs) of TRA versus transfemoral access (TFA) for neuroendovascular procedures remains unclear. A systematic literature review and meta-analysis using a random effects model was conducted to investigate the pooled odds ratios (OR) of ASCs and NASCs. Randomized, case-control, and cohort studies comparing access-related complications were analyzed. An assessment of study heterogeneity and publication bias was also completed. Seventeen comparative studies met the inclusion criteria for final analysis. Overall, there was a composite ASC rate of 1.8% (49/2767) versus 3.2% (168/5222) for TRA and TFA, respectively (P<0.001). TRA was associated with a lower odds of ASC compared with TFA (OR 0.42; 95% CI 0.25 to 0.68, P<0.001, I On meta-analysis, the current literature indicates that TRA is associated with a lower incidence of ASCs compared with TFA, but is not associated with a lower rate of NASCs.

Sections du résumé

BACKGROUND BACKGROUND
Transradial access (TRA) has gained increased usage among neurointerventionalists. However, the overall safety profile of access site complications (ASCs) and non-access site complications (NASCs) of TRA versus transfemoral access (TFA) for neuroendovascular procedures remains unclear.
METHODS METHODS
A systematic literature review and meta-analysis using a random effects model was conducted to investigate the pooled odds ratios (OR) of ASCs and NASCs. Randomized, case-control, and cohort studies comparing access-related complications were analyzed. An assessment of study heterogeneity and publication bias was also completed.
RESULTS RESULTS
Seventeen comparative studies met the inclusion criteria for final analysis. Overall, there was a composite ASC rate of 1.8% (49/2767) versus 3.2% (168/5222) for TRA and TFA, respectively (P<0.001). TRA was associated with a lower odds of ASC compared with TFA (OR 0.42; 95% CI 0.25 to 0.68, P<0.001, I
CONCLUSION CONCLUSIONS
On meta-analysis, the current literature indicates that TRA is associated with a lower incidence of ASCs compared with TFA, but is not associated with a lower rate of NASCs.

Identifiants

pubmed: 34479985
pii: neurintsurg-2021-018032
doi: 10.1136/neurintsurg-2021-018032
doi:

Types de publication

Journal Article Meta-Analysis Systematic Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

820-825

Informations de copyright

© Author(s) (or their employer(s)) 2022. No commercial re-use. See rights and permissions. Published by BMJ.

Déclaration de conflit d'intérêts

Competing interests: JB: Consulting relationships with Asahi Intecc and AvantGarde Health for work on coronary guidewires.

Auteurs

Derrek Schartz (D)

Imaging Sciences, University of Rochester Medical Center, Rochester, New York, USA.

Sajal Medha K Akkipeddi (SMK)

Neurosurgery, University of Rochester Medical Center, Rochester, New York, USA.

Nathaniel Ellens (N)

Neurosurgery, University of Rochester Medical Center, Rochester, New York, USA.

Redi Rahmani (R)

Neurosurgery, University of Rochester Medical Center, Rochester, New York, USA.

Gurkirat Singh Kohli (GS)

Neurosurgery, University of Rochester Medical Center, Rochester, New York, USA.

Jeffrey Bruckel (J)

Cardiology, University of Rochester Medical Center, Rochester, New York, USA.

Justin M Caplan (JM)

Neurosurgery, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA.

Thomas K Mattingly (TK)

Neurosurgery, University of Rochester Medical Center, Rochester, New York, USA.

Tarun Bhalla (T)

Neurosurgery, University of Rochester Medical Center, Rochester, New York, USA.

Matthew T Bender (MT)

Neurosurgery, University of Rochester Medical Center, Rochester, New York, USA matthew_bender@urmc.rochester.edu.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH